Literature DB >> 14582571

Physical and mental health problems associated with the use of alcohol and drugs.

Manuella Adrian1, Shawn J Barry.   

Abstract

The nature and extent of treated health problems in patients with problems related to the use of alcohol and drugs (including both licit and illicit drugs) were compared with the morbidity levels of all patients treated for all conditions in Canada. The morbidity experience of all patients with alcohol or drug (A/D) diagnoses treated as inpatients (n = 52,200 cases) in all Ontario hospitals in 1985-1986 (based on Hospital Medical Records Institute [HMRI] data) was compared with that of the total population of all inpatients treated in all Canadian hospitals using age-sex standardized morbidity ratios (SMR) and adjusting for multiple diagnoses. Of A/D cases, 32% were admitted with a primary A/D diagnosis and 68% with a secondary A/D diagnosis; 17% of A/D cases had multiple A/D diagnosis. On average, cases with a primary A/D diagnosis had 29% more diagnoses per case than all cases treated in Ontario. SMRs were highest for cases with diagnoses relating to the use or misuse of licit drugs (SMR = 13.32 and 3.51 for those with primary and secondary drug diagnoses, respectively), intermediate for illicit drug cases (SMR = 8.87 vs. 4.74 for primary and secondary diagnoses, respectively), and lowest for patients with alcohol diagnoses (SMR = 6.68 and 4.12 for primary and secondary diagnoses, respectively). Excess morbidity for alcohol cases affected more diagnostic categories and body systems, being at a higher level than for drug cases. Alcohol or drug cases had particularly high SMRs for mental disorders, infectious and parasitic conditions, and injury and poisoning diagnoses. Alcohol or drug cases had reduced reproductive morbidity: for complications of pregnancy, childbirth, and the puerperium, SMR = 0.04 to 0.24 for cases with primary A/D diagnoses and SMR = 0.12 to 0.89 for those with secondary A/D diagnoses. Cases with drug diagnoses had a considerable reduction in SMR for certain conditions originating in the perinatal period: SMR = 0.0 for cases with primary drug diagnoses and SMR = 0.0 for secondary illicit drug diagnoses cases and SMR = 0.18 for secondary licit drug diagnoses cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582571     DOI: 10.1081/ja-120024230

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  16 in total

Review 1.  Exercise-based treatments for substance use disorders: evidence, theory, and practicality.

Authors:  Sarah E Linke; Michael Ussher
Journal:  Am J Drug Alcohol Abuse       Date:  2014-11-14       Impact factor: 3.829

2.  Alcohol and drug use among patients presenting to an inner-city emergency department: a latent class analysis.

Authors:  Frederic C Blow; Maureen A Walton; Kristen L Barry; Regan L Murray; Rebecca M Cunningham; Lynn S Massey; Stephen T Chermack; Brenda M Booth
Journal:  Addict Behav       Date:  2010-12-29       Impact factor: 3.913

3.  The Evolution of Aging With Pride-National Health, Aging, and Sexuality/Gender Study: Illuminating the Iridescent Life Course of LGBTQ Adults Aged 80 Years and Older in the United States.

Authors:  Karen Fredriksen Goldsen; Hyun-Jun Kim; Hyunzee Jung; Jayn Goldsen
Journal:  Int J Aging Hum Dev       Date:  2019-04-08

4.  Medical problems among adolescents in U.S. mental health services: relationship to functional impairment.

Authors:  Lynn A Warner
Journal:  J Behav Health Serv Res       Date:  2006-07       Impact factor: 1.505

5.  Healthcare utilization among patients with psychiatric hospitalization admitted through the emergency department (ED): A claims-based study.

Authors:  Wenna Xi; Samprit Banerjee; Robert B Penfold; Gregory E Simon; George S Alexopoulos; Jyotishman Pathak
Journal:  Gen Hosp Psychiatry       Date:  2020-10-07       Impact factor: 3.238

6.  Resets do not appear to increase the rate of adverse events or prolong relapse in voucher-based reinforcement therapy.

Authors:  Brian E Versek; Carolyn M Carpenedo; Beth J Rosenwasser; Karen Leggett Dugosh; Elena Bresani; Kimberly C Kirby
Journal:  J Subst Abuse Treat       Date:  2010-07-03

7.  Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts?

Authors:  Nancy M Petry; John M Roll; Bruce J Rounsaville; Samuel A Ball; Maxine Stitzer; Jessica M Peirce; Jack Blaine; Kimberly C Kirby; Dennis McCarty; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2008-12

8.  Alcohol, tobacco, and nonmedical drug use in older U.S. Adults: data from the 2001/02 national epidemiologic survey of alcohol and related conditions.

Authors:  Alison A Moore; Mitchell P Karno; Christine E Grella; James C Lin; Umme Warda; Diana H Liao; Peifeng Hu
Journal:  J Am Geriatr Soc       Date:  2009-10-26       Impact factor: 5.562

9.  Medical and substance use comorbidity in bipolar disorder.

Authors:  David E Kemp; Keming Gao; Stephen J Ganocy; Emily Caldes; Kathryn Feldman; Philip K Chan; Carla Conroy; Sarah Bilali; Robert L Findling; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2008-12-18       Impact factor: 4.839

10.  Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial.

Authors:  Sion Kim Harris; Ladislav Csémy; Lon Sherritt; Olga Starostova; Shari Van Hook; Julie Johnson; Suzanne Boulter; Traci Brooks; Peggy Carey; Robert Kossack; John W Kulig; Nancy Van Vranken; John R Knight
Journal:  Pediatrics       Date:  2012-05-07       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.